CNK-UT / ST Phi Therap, Zhejiang University - LARVOL DELTA

Universal CNK-UT Therapy for Refractory aGVHD (clinicaltrials.gov) - P1 | N=23 | Recruiting | Sponsor: First Affiliated Hospital of Zhejiang University

New P1 trial • Acute Graft versus Host Disease • Graft versus Host Disease • Immunology • REG3A

Universal Dual-target NKG2D-NKp44 CAR-T Cells in Advanced Solid Tumors (clinicaltrials.gov) - P1 | N=36 | Recruiting | Sponsor: Zhejiang University

CAR T-Cell Therapy • Metastases • New P1 trial • Breast Cancer • Cholangiocarcinoma • Colorectal Cancer • Gastrointestinal Cancer • Hepatocellular Cancer • Melanoma • Oncology • Renal Cell Carcinoma • Solid Tumor • Triple Negative Breast Cancer • IL2